Read Time:56 Second

Clinical Researchers have released some good news about a possible treatment for  coronavirus on Wednesday.

The US Food and Drug Administration has not yet approved any drugs for the treatment of the coronavirus. But it plans to announce an emergency-use authorization for remdesivir, according to The New York Times.
Data from the trial on more than 1,000 severely ill patients in 75 hospitals around the world show that patients put on the drug recovered 31% faster than similar patients who were given a placebo drug instead. Remdesivir cut recovery time from a median of 15 days to 11 days.

Scientists also suggested the drug could have an effect on survival. In the group on the drug, 8% died, compared with 11% among those given a placebo.

Remdesivir, made by the US company Gilead, is not a cure for Covid-19 and these results must be confirmed by more data, but experts think it could potentially help those who are acutely ill, probably in combination with other drugs that are yet to be shown to work. Multiple trials are taking place in hospitals around the world.

0 0

About Post Author

Denis Chilaka

Denis Chilaka is a passionate blogger and an amazing writer. He is a health and fitness enthusiast who loves sharing helpful information to people.
Happy
Happy
0 %
Sad
Sad
0 %
Excited
Excited
0 %
Sleppy
Sleppy
0 %
Angry
Angry
0 %
Surprise
Surprise
0 %

By Denis Chilaka

Denis Chilaka is a passionate blogger and an amazing writer. He is a health and fitness enthusiast who loves sharing helpful information to people.

One thought on “Antiviral Drug Remdesivir Clinical Trials Yields Positive For Treating Coronavirus Patients”

Leave a Reply

Your email address will not be published. Required fields are marked *